Yi Fei Yang
Direttore/Membro del Consiglio presso RED PHASE INC.
Posizioni attive di Yi Fei Yang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RED PHASE INC. | Direttore/Membro del Consiglio | 22/03/2021 | - |
| Independent Dir/Board Member | 22/03/2021 | - | |
| CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD | Direttore/Membro del Consiglio | 20/12/2022 | - |
| Independent Dir/Board Member | 20/12/2022 | - | |
Xiamen Zeesan Biotech Co., Ltd.
 Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Direttore/Membro del Consiglio | 23/08/2021 | - |
| Independent Dir/Board Member | 23/08/2021 | - |
Storia della carriera di Yi Fei Yang
Statistiche
Distribuzione geografica
| Cina | 4 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Settori
| Electronic Technology | 2 |
| Health Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| RED PHASE INC. | Electronic Technology |
| CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD | Commercial Services |
| Aziende private | 1 |
|---|---|
Xiamen Zeesan Biotech Co., Ltd.
Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Health Services |
- Borsa valori
- Insiders
- Yi Fei Yang
- Esperienza
